Evidence map›Paper›PMID 39250782›Full record

ArticleJMIR medical informatics2024

A Case Demonstration of the Open Health Natural Language Processing Toolkit From the National COVID-19 Cohort Collaborative and the Researching COVID to Enhance Recovery Programs for a Natural Language Processing System for COVID-19 or Postacute Sequelae of SARS CoV-2 Infection: Algorithm Development and Validation.

Andrew Wen, Liwei Wang, Huan He, Sunyang Fu, Sijia Liu, David A Hanauer, Daniel R Harris, Ramakanth Kavuluru, Rui Zhang, Karthik Natarajan and 25 more

Abstract read
In one paragraph

Article in JMIR medical informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Andrew Wen *Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0001-9090-8028
Liwei Wang *Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0001-9970-8604
Huan HeDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0003-1312-4195
Sunyang FuDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0003-1691-5179
Sijia LiuDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0001-9763-1164
David A HanauerDepartment of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.ORCID https://orcid.org/0000-0001-6931-3791
Daniel R HarrisInstitute for Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky, Lexington, KY, United States.ORCID https://orcid.org/0000-0001-9139-3433
Ramakanth KavuluruDivision of Biomedical Informatics, Department of Internal Medicine, University of Kentucky, Lexington, KY, United States.ORCID https://orcid.org/0000-0003-1238-9378
Rui ZhangDivision of Health Data Science, University of Minnesota Medical School, Minneapolis, MN, United States.ORCID https://orcid.org/0000-0001-8258-3585
Karthik NatarajanDepartment of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, United States.ORCID https://orcid.org/0000-0002-9066-9431
Nishanth P PavinkurveDepartment of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, United States.ORCID https://orcid.org/0000-0003-3135-3047
Janos HajagosDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0001-6251-9586
Sritha RajupetDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0002-3991-8420
Veena LingamDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0001-5335-3721
Mary SaltzDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0002-1554-5738
Corey ElowskyDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0002-5481-8305
Richard A MoffittDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0003-2723-5902
Farrukh M KoraishyDivision of Nephrology, Stony Brook Medicine, Stony Brook, NY, United States.ORCID https://orcid.org/0000-0001-6974-5674
Matvey B PalchukTriNetX LLC, Cambridge, MA, United States.ORCID https://orcid.org/0000-0002-7737-8752
Jordan DonovanTriNetX LLC, Cambridge, MA, United States.ORCID https://orcid.org/0009-0005-8820-7819
Lora LingreyTriNetX LLC, Cambridge, MA, United States.ORCID https://orcid.org/0009-0009-1209-0983
Garo Stone-DerHagopianTriNetX LLC, Cambridge, MA, United States.ORCID https://orcid.org/0009-0001-8708-7764
Robert T MillerClinical and Translational Science Institute, Tufts Medical Center, Boston, MA, United States.ORCID https://orcid.org/0000-0002-1787-2855
Andrew E WilliamsClinical and Translational Science Institute, Tufts Medical Center, Boston, MA, United States.ORCID https://orcid.org/0000-0002-0692-412X
Peter J LeeseNorth Carolina Translational and Clinical Sciences Institute, University of North Carolina School of Medicine, Chapel Hill, NC, United States.ORCID https://orcid.org/0000-0001-9730-1675
Paul I KovachNorth Carolina Translational and Clinical Sciences Institute, University of North Carolina School of Medicine, Chapel Hill, NC, United States.ORCID https://orcid.org/0009-0007-1562-1095
Emily R PfaffNorth Carolina Translational and Clinical Sciences Institute, University of North Carolina School of Medicine, Chapel Hill, NC, United States.ORCID https://orcid.org/0000-0002-6840-9756
Mikhail ZemmelUniversity of Virginia, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0002-2434-2537
Robert D PatesUniversity of Virginia, Charlottesville, VA, United States.ORCID https://orcid.org/0009-0005-9949-4139
Nick GutheDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID https://orcid.org/0009-0003-8409-4605
Melissa A HaendelUniversity of Colorado Anschutz Medical Campus, Denver, CO, United States.ORCID https://orcid.org/0000-0001-9114-8737
Christopher G ChuteSchools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD, United States.ORCID https://orcid.org/0000-0001-5437-2545
Hongfang LiuDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0003-2570-3741
National COVID Cohort Collaborative *see Acknowledgments, .
RECOVER Initiative *see Acknowledgments, .

Funding

OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational and Clinical Sciences Institute (NC TraCS)UM1TR004406 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS J SHAHEEN · 2023 to 2026
$37.5M
Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
CD2H - The National COVID Cohort Collaborative (N3C) IDeA CTR CollaborationU24TR002306 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CHUTE, CHRISTOPHER G, EICHMANN, DAVID A. · 2017 to 2021
$28.9M
The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
Open Health Natural Language Processing CollaboratoryU01TR002062 · NCATS · MAYO CLINIC ROCHESTER · PI JIANG, XIAOQIAN, LIU, HONGFANG · 2017 to 2021
$7.6M
Advanced End-to-End Relation Extraction with Deep Neural NetworksR01LM013240 · NLM · UNIVERSITY OF KENTUCKY · PI KAVULURU, VENKATA NAGA RAMAKANTH · 2020 to 2023
$1.4M
NCATS NIH HHS U01 TR002062NCATS NIH HHS U24 TR002306NCATS NIH HHS UL1 TR001998NCATS NIH HHS UL1 TR002240NCATS NIH HHS UL1 TR002489NCATS NIH HHS UL1 TR003015NCATS NIH HHS UL1 TR003098NCATS NIH HHS UM1 TR004406NHLBI NIH HHS OT2 HL161847NLM NIH HHS R01 LM013240
6 · The paper itself

Abstract

backgroundA wealth of clinically relevant information is only obtainable within unstructured clinical narratives, leading to great interest in clinical natural language processing (NLP). While a multitude of approaches to NLP exist, current algorithm development approaches have limitations that can slow the development process. These limitations are exacerbated when the task is emergent, as is the case currently for NLP extraction of signs and symptoms of COVID-19 and postacute sequelae of SARS-CoV-2 infection (PASC).

objectiveThis study aims to highlight the current limitations of existing NLP algorithm development approaches that are exacerbated by NLP tasks surrounding emergent clinical concepts and to illustrate our approach to addressing these issues through the use case of developing an NLP system for the signs and symptoms of COVID-19 and PASC.

methodsWe used 2 preexisting studies on PASC as a baseline to determine a set of concepts that should be extracted by NLP. This concept list was then used in conjunction with the Unified Medical Language System to autonomously generate an expanded lexicon to weakly annotate a training set, which was then reviewed by a human expert to generate a fine-tuned NLP algorithm. The annotations from a fully human-annotated test set were then compared with NLP results from the fine-tuned algorithm. The NLP algorithm was then deployed to 10 additional sites that were also running our NLP infrastructure. Of these 10 sites, 5 were used to conduct a federated evaluation of the NLP algorithm.

resultsAn NLP algorithm consisting of 12,234 unique normalized text strings corresponding to 2366 unique concepts was developed to extract COVID-19 or PASC signs and symptoms. An unweighted mean dictionary coverage of 77.8% was found for the 5 sites.

conclusionsThe evolutionary and time-critical nature of the PASC NLP task significantly complicates existing approaches to NLP algorithm development. In this work, we present a hybrid approach using the Open Health Natural Language Processing Toolkit aimed at addressing these needs with a dictionary-based weak labeling step that minimizes the need for additional expert annotation while still preserving the fine-tuning capabilities of expert involvement.

Indexed as

clinical information extractionclinical phenotypingCOVIDCOVID-19extractextractionnarrativesnatural language processingNLPOHNLPOpen Health Natural Language ProcessingPASCphenotypephenotypingSARS-CoV-2unstructured

Identifiers

PMID39250782
PMCPMC11420592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.